Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

(Q27852946)

English

Characterization of the novel and specific PI3Kα inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Characterization of the novel and specific PI3Kα inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials (English)
Christine Fritsch
0 references
Alan Huang
0 references
Christian Chatenay-Rivauday
0 references
Christian Schnell
0 references
Anupama Reddy
0 references
Manway Liu
0 references
Audrey Kauffmann
0 references
Daniel Guthy
0 references
Dirk Erdmann
0 references
Alain De Pover
0 references
Pascal Furet
0 references
Hui Gao
0 references
Stephane Ferretti
0 references
Youzhen Wang
0 references
Joerg Trappe
0 references
Saskia M Brachmann
0 references
Sauveur-Michel Maira
0 references
Christopher Wilson
0 references
Markus Boehm
0 references
Patrick Chene
0 references
Robert Cozens
0 references
Joseph Lehar
0 references
Robert Schlegel
0 references
Giorgio Caravatti
0 references
Francesco Hofmann
0 references
William R Sellers
0 references
May 2014
0 references
13
0 references
5
0 references
1117-29
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit